These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21054756)

  • 21. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of weight loss resulting from a combined low-fat diet/exercise regimen on low-density lipoprotein particle size and distribution in obese women.
    Varady KA; Lamarche B; Santosa S; Demonty I; Charest A; Jones PJ
    Metabolism; 2006 Oct; 55(10):1302-7. PubMed ID: 16979399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.
    Shin MJ; Hyun YJ; Kim OY; Kim JY; Jang Y; Lee JH
    Int J Obes (Lond); 2006 Oct; 30(10):1529-34. PubMed ID: 16552406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
    Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
    Williams K; Sniderman AD; Sattar N; D'Agostino R; Wagenknecht LE; Haffner SM
    Circulation; 2003 Nov; 108(19):2312-6. PubMed ID: 14581403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, weight loss, and cardiovascular health: is oxidative capacity a missing link?
    Phillips SA
    Am J Hypertens; 2008 Dec; 21(12):1277. PubMed ID: 19020508
    [No Abstract]   [Full Text] [Related]  

  • 28. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipokines--targeting a root cause of cardiometabolic risk.
    Bakhai A
    QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study.
    Christiansen T; Paulsen SK; Bruun JM; Pedersen SB; Richelsen B
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E824-31. PubMed ID: 20086201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary regulation of glucose metabolism in metabolic syndrome.
    Bulló M; Cózar-Torrell P; Salas-Salvadó J
    Curr Vasc Pharmacol; 2013 Nov; 11(6):928-45. PubMed ID: 24168442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and the "obesity paradox" in cardiovascular diseases.
    Lavie CJ; Milani RV; Ventura HO
    Clin Pharmacol Ther; 2011 Jul; 90(1):23-5. PubMed ID: 21691270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthy weight, healthy shape.
    Hariram V; Talwar KK
    Indian J Med Res; 2005 Sep; 122(3):187-90. PubMed ID: 16251771
    [No Abstract]   [Full Text] [Related]  

  • 35. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
    Scherer PE; Hill JA
    Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel Nutritional and Dietary Approaches to Weight Loss for the Prevention of Cardiovascular Disease: Ketogenic Diet, Intermittent Fasting, and Bariatric Surgery.
    Becker A; Gaballa D; Roslin M; Gianos E; Kane J
    Curr Cardiol Rep; 2021 Jun; 23(7):85. PubMed ID: 34081228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia.
    Al-Waili N; Salom K; Al-Ghamdi A; Ansari MJ; Al-Waili A; Al-Waili T
    J Med Food; 2013 Dec; 16(12):1063-78. PubMed ID: 24328699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity.
    Musaad S; Haynes E
    IARC Sci Publ; 2011; (163):441-52. PubMed ID: 22997876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Dynamic Platelet Transcriptome in Obesity and Weight Loss.
    Ezzaty Mirhashemi M; Shah RV; Kitchen RR; Rong J; Spahillari A; Pico AR; Vitseva O; Levy D; Demarco D; Shah S; Iafrati MD; Larson MG; Tanriverdi K; Freedman JE
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):854-864. PubMed ID: 33297754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight loss reduces risk of developing cardiovascular disease (CVD)--need for effective weight loss strategies grows as prevalence of obesity increases.
    Cardiovasc J S Afr; 2001; 12(1):56-7. PubMed ID: 11474690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.